Tibet Rhodiola Pharmaceutical Holding Co (600211) — Free Cash Flow Generation Index
Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Free Cash Flow Generation Index of 0.98x as of December 2025. Free cash flow of CN¥292.88 Million represents 1% of operating cash flow (CN¥297.86 Million). Explore 600211 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tibet Rhodiola Pharmaceutical Holding Co Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Tibet Rhodiola Pharmaceutical Holding Co across 25 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Tibet Rhodiola Pharmaceutical Holding Co.
Annual Free Cash Flow Generation for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Year-by-year Free Cash Flow Generation Index for Tibet Rhodiola Pharmaceutical Holding Co. Check 600211 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.98x | CN¥1.01 Billion | CN¥1.03 Billion | CN¥15.96 Million | ▲ +2.3% |
| 2024 | 0.96x | CN¥957.19 Million | CN¥994.79 Million | CN¥37.60 Million | ▼ 0.0% |
| 2023 | 0.96x | CN¥1.04 Billion | CN¥1.08 Billion | CN¥21.69 Million | ▲ +9.6% |
| 2022 | 0.88x | CN¥735.41 Million | CN¥837.38 Million | CN¥101.96 Million | ▲ +645.2% |
| 2021 | -0.16x | CN¥-59.05 Million | CN¥366.53 Million | CN¥425.58 Million | ▼ -133.3% |
| 2020 | 0.48x | CN¥206.88 Million | CN¥428.17 Million | CN¥221.29 Million | ▼ -46.3% |
| 2019 | 0.90x | CN¥440.60 Million | CN¥489.59 Million | CN¥49.00 Million | ▼ -2.1% |
| 2018 | 0.92x | CN¥265.85 Million | CN¥289.22 Million | CN¥23.37 Million | ▲ +116.3% |
| 2017 | -5.65x | CN¥-516.52 Million | CN¥91.46 Million | CN¥607.98 Million | ▼ -687.4% |
| 2016 | 0.96x | CN¥240.56 Million | CN¥250.21 Million | CN¥9.64 Million | ▲ +4.5% |
| 2015 | 0.92x | CN¥123.27 Million | CN¥133.93 Million | CN¥10.66 Million | ▲ +4.8% |
| 2013 | 0.88x | CN¥245.10 Million | CN¥279.22 Million | CN¥34.12 Million | ▼ -4.7% |
| 2012 | 0.92x | CN¥51.78 Million | CN¥56.20 Million | CN¥4.42 Million | ▲ +13.9% |
| 2011 | 0.81x | CN¥9.78 Million | CN¥12.09 Million | CN¥2.31 Million | ▲ +326.8% |
| 2010 | -0.36x | CN¥-677.71K | CN¥1.90 Million | CN¥2.58 Million | ▼ -145.0% |
| 2009 | 0.79x | CN¥14.18 Million | CN¥17.88 Million | CN¥3.70 Million | ▲ +2.2% |
| 2008 | 0.78x | CN¥16.66 Million | CN¥21.46 Million | CN¥4.80 Million | ▲ +47.2% |
| 2006 | 0.53x | CN¥17.73 Million | CN¥33.63 Million | CN¥15.90 Million | ▼ -15.8% |
| 2005 | 0.63x | CN¥11.85 Million | CN¥18.92 Million | CN¥7.07 Million | ▲ +78.2% |
| 2004 | 0.35x | CN¥9.46 Million | CN¥26.90 Million | CN¥17.45 Million | ▼ -31.8% |
| 2003 | 0.52x | CN¥24.33 Million | CN¥47.20 Million | CN¥22.88 Million | ▲ +124.4% |
| 2002 | -2.11x | CN¥-69.29 Million | CN¥32.85 Million | CN¥102.14 Million | ▲ +49.2% |
| 2001 | -4.15x | CN¥-64.25 Million | CN¥15.47 Million | CN¥79.72 Million | ▲ +12.8% |
| 2000 | -4.76x | CN¥-97.89 Million | CN¥20.55 Million | CN¥118.45 Million | ▲ +82.5% |
| 1999 | -27.15x | CN¥-61.00 Million | CN¥2.25 Million | CN¥63.25 Million | — |